Role of CVBF



TEDDY is a scientific independent multidisciplinary and multinational network including 50 members from 20 EU  and non EU-countries, aimed to favor the integration of the paediatric pharmacological research activities and address the most important needs of the paediatric research. It is arisen from the FP6 funded Task-force in Europe for Drug Development for the Young and in 2017 has acquired an autonomous legal status allowing the Network to be fully represented and consolidated in the paediatric research community framework.

TEDDY is a category 1 network member of Enpr-EMA, the European Network of Paediatric Research at the European Medicines Agency and registered at ENCePP (the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance).

The main objective of TEDDY network is to promote research on medicinal products in children providing methodological expertise and implementing good practices, Standard Operating Procedures (SOPs) and tools to plan, design and perform clinical studies at national and international level. Thanks to the international recognition and the wide geographical representativeness, TEDDY is able to provide the paediatric community of: easy dissemination of relevant information; consultation on paediatric drug development issues; involvement in paediatric studies; documents and recommendations in the sector of paediatric study methodology.


  • Assistance Publique – Hôpitaux de Paris, France;
  • Assiut university Faculty of Medicine, Egypt;
  • Azienda Ospedaliera Antonio Cardarelli, Naples, Italy;
  • Azienda Ospedaliera di Padova, Italy;
  • Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy;
  • Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari, Italy;
  • Azienda Ospedaliero-Universitaria di Modena, Italy;
  • Barts Health NHS Trust, London, United Kingdom;
  • Cairo University, Egypt;
  • Center for Strategic Research North-West as Coordinator of the Alliance for Translational Medicine, St. Petersburg, Russia;
  • Centre National de Greffe de Moelle Osseuse, Tunis, Tunisia;
  • Charité – Universitätsmedizin Berlin, Germany;
  • Childhood Cancer International, Nieuwegein, The Netherlands;
  • Consorzio per Valutazioni Biologiche e Farmacologiche, Bari, Italy (Coordinator);
  • Consorzio per Valutazioni Biologiche e Farmacologiche – Dege e shoqerise se huaj, Tirana,  Albania;
  • Erasmus MC Sophia Children’s Hospital, Rotterdam, The Netherlands;
  • Erasmus Universitair Medisch Centrum Rotterdam, The Netherlands;
  • Espace Ethique Méditerranéen CHU Marseille (AP-HM/Aix-Marseille Université), France;
  • Fondazione PENTA Onlus, Padua, Italy;
  • Fondazione per la Ricerca Farmacologica ‘Gianni Benzi’ Onlus, Bari, Italy;
  • Fundación para la Investigación del Hospital Universitario y Politécnico La Fe de la Comunidad Valenciana, Spain;
  • Fundación para la Investigación, Desenvolvemento e Innovación Ramón Domínguez, Santiago de Compostela, Spain;
  • Fundaciò Sant Joan de Déu, Barcelona, Spain;
  • Geniko Nosokomeio Paidon Athinon I Agia Sophia-Paidon Pentelis, Athens, Greece;
  • Gothia Forum Sahlgrenska University Hospital, Göteborg, Sweden;
  • Gruppo Italiano per gli Studi di Farmacoeconomia, Pavia,  Italy;
  • Hospital Clínico Universitario de Santiago de Compostela, Spain;
  • Hospital Universitario 12 de Octubre, Madrid, Spain;
  • Hospital Universitario La Paz, Madrid Spain;
  • Inserm SC10, Villejuif , France;
  • Institute of Physiology of ASCR, v.v.i., Praha, Czech Republic;
  • Instytut Pomnik – Centrum Zdrowia Dziecka, Warszawa, Poland;
  • Istituto Superiore di Sanità, Rome, Italy;
  • Medical and Public Health Services of the Cyprus Ministry of Health, Cyprus;
  • National and Kapodistrian University of Athens, Greece;
  • Ospedale Pediatrico Bambino Gesù, Rome, Italy;
  • PHARM – PHArmaceutical Research Management Srl, Lodi, Italy;
  • PharmaSich Plus, LLC, Kiev, Ukraine;
  • Phoenix Clinical Research, Beirut, Lebanon;
  • Romanian Angel Appeal Foundation, Bucharest, Romania;
  • Società Servizi Telematici Srl, Padua,  Italy;
  • Technion – Israel Institute of Technology, Haifa, Israel;
  • Università degli Studi “Gabriele D’Annunzio” Chieti Pescara, Italy;
  • Università degli Studi di Napoli Federico II, Dipartimento di Pediatria, Italy;
  • Universitätsklinikum Erlangen, Germany;
  • University College London, United Kingdom;
  • University Hospital Center “Mother Teresa”, Tirana, Albania;
  • University of Edinburgh, United Kingdom;
  • University of Honk Kong, China;
  • University of Liverpool, United Kingdom.